Cabozanix

Cabozanix is an anti-cancer drug used to treat medullary thyroid cancer, renal cell carcinoma, and hepatocellular carcinoma.

Approved by the US FDA in November 2012 for medullary thyroid cancer and in April 2016 for kidney cancer.